Evidence map›Paper›PMID 41792154›Full record

ArticleScientific reports2026

Synthesis and structural insights of tunable NiO

Hila Shalom, Shifra Tahover, Olga Brontvein, Iddo Pinkas, Raanan Carmieli, Lena Yadgarov

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hila ShalomDepartment of Chemical Engineering, Ariel University, Ariel, Israel.
Shifra TahoverDepartment of Chemical Engineering, Ariel University, Ariel, Israel.
Olga BrontveinDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.
Iddo PinkasDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.
Raanan CarmieliDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.
Lena YadgarovDepartment of Chemical Engineering, Ariel University, Ariel, Israel. lenay@ariel.ac.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report for the synthesis, structural characterization, and photocatalytic activity of NiOₓ-MoO₃-MoS₂ nanocomposites (NCs) with different ratios of MoO₃-MoS₂ (labeled as NMOS, N = NiOₓ, MO = MoO₃, S = MoS₂). NiOₓ nanoparticles (NPs) were synthesized via a sol-gel method and subsequently annealed with different Mo-precursor ratios to form NMOS NCs. Structural analyses (XRD, TEM, XPS, Raman) confirmed a non-stoichiometric NiOₓ core, encapsulated by MoO₃-MoS₂ domains. Optical studies showed band gap tuning from 3.53 eV (NiOₓ) to 2.92 eV (NMOS-III), enhancing visible-light absorption. Photocatalytic activity, evaluated through methylene blue (MB) degradation, revealed NMOS-I exhibited the highest efficiency due to balanced phase composition and efficient radical generation, with rapid adsorption and degradation in the first 5 min, followed by slower equilibrium adsorption. In contrast, excessive Mo-precursor loading in NMOS-III formed a secondary phase (e.g., NiS), leading to recombination losses and reduced efficiency. This work represents the first demonstration of tunable ternary NMOS NCs and elucidates how precise control of phase ratios and heterointerfaces dramatically enhances photocatalytic activity. These findings highlight the role of phase distribution and interfacial chemistry, offering new possibilities for tailoring NMOS NCs for photocatalytic and environmental applications.

Indexed as

Dye degradationMoO2MoS2NanocompositesNanoparticlesNiO

Identifiers

PMID41792154
PMCPMC13083871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.